TheCoroRevolution SIGNED

Project "TheCoroRevolution" data sheet

The following table provides information about the project.

 Partnership

Take a look of project's partnership.

Map

+-

Leaflet | Map data © OpenStreetMap contributors, CC-BY-SA, Imagery © Mapbox

 Project objective

Never before has so much been known about the multitude of health benefits of breastfeeding, yet we are in the midst of a global breastfeeding crisis. The single most commonly identified reason globally is maternal concern regarding insufficient breast milk supply. Even when support and education are optimised to minimise unnecessary anxiety, the rates of breastfeeding continue to be abysmal. All commercial and research methods developed to date to address the issue have failed. The Coro is a novel microsensor embedded within the standard nipple shield, providing accurate, real-time milk volume data directly to the mother via an app. Our data will also generate volume rates across countries, in specific maternal and baby age populations, will correlate volume to baby weight and allow multiple-variable, deep data mining. Through collaborations with research groups and health agencies, the data generated will finally fill the fundamental gap in breastfeeding knowledge and assist future efforts to increase breastfeeding rates on a global level. The commercial opportunity is vast with virtually no competitors and perfectly aligned with global trends in wearable health technology. We have a strong founding team who have leveraged their personal predicament and professional backgrounds to invent a game-changing product. We have protected our valuable IP, built a partnership with a leading university research group to clinically trial the Coro, signed our first distributors and won several awards. Our vision is to become the primary source for breastfeeding volume measurement products, information, and analysis. The SMEI would ensure we bridge the gap to market by funding the product’s industrialisation, pre-commercialisation and clinical validation to build crucial scientific credibility. This would allow our company to harness societal and policy trends and scientific and technological advances to finally pivot the global tipping point in favour of breastfeeding.